Niskanen L K, Suhonen M, Siitonen O, Lehtinen J M, Uusitupa M I
Department of Medicine, Kuopio University Central Hospital, Finland.
Atherosclerosis. 1990 Sep;84(1):61-71. doi: 10.1016/0021-9150(90)90009-8.
The purpose of the present study was to assess among a representative group of middle-aged newly diagnosed type 2 diabetics and control subjects the baseline prevalence and 5-year incidence of arterial calcifications of aorta and lower limb and their relationship to cardiovascular morbidity. The relationship of baseline risk factors to the development of arterial calcifications was also studied. At the time of diagnosis the age-adjusted prevalence of aortic and lower limb intimal calcifications was higher in diabetics than in control subjects (aortic calcifications: 29 vs. 17% for men, P = 0.05; 26 vs. 19% for women, P = 0.06; lower limb intimal calcifications: 24 vs. 12% for men, P = 0.02; 10 vs. 7% for women; P = NS), whereas no significant difference in baseline prevalence of lower limb medial calcifications was observed (15 vs. 21% for men, 9 vs. 10% for women). The 5-yr incidence of aortic calcifications in both sexes and of lower limb calcifications in men was similar in diabetic and control subjects, but the incidence of lower limb calcifications was higher in diabetic women than in control women (intimal: 33 vs. 11%, P = 0.009: medial: 29 vs. 14%, P = 0.05). The baseline prevalence of abdominal aortic (37 vs. 22%, P = NS for diabetics; 42 vs. 16%, P = 0.02 for control subjects), lower limb intimal (24 vs. 16% for diabetics, P = NS; 15 vs. 7% for control subjects, P = NS) and medial calcifications (23 vs. 7% for diabetics, P = 0.03) were higher in subjects who developed intermittent claudication during the follow-up than in those free of it at the 5-yr examination. Abnormalities in VLDL-metabolism and high systolic blood pressure were associated with the development of aortic calcification in diabetic subjects. In conclusion, already at the time of diagnosis atherosclerotic calcifications are more prevalent in type 2 diabetics than in nondiabetic subjects. During the follow-up diabetic women, but not men, had higher incidence of lower limb intimal and medial calcifications than non-diabetic subjects. Arterial calcifications tended to be associated with the development of intermittent claudication during the follow-up in diabetic and control subjects.
本研究的目的是在一组具有代表性的中年新诊断2型糖尿病患者和对照受试者中,评估主动脉和下肢动脉钙化的基线患病率、5年发病率及其与心血管疾病发病率的关系。还研究了基线风险因素与动脉钙化发展的关系。在诊断时,糖尿病患者主动脉和下肢内膜钙化的年龄校正患病率高于对照受试者(主动脉钙化:男性为29%对17%,P = 0.05;女性为26%对19%,P = 0.06;下肢内膜钙化:男性为24%对12%,P = 0.02;女性为10%对7%,P = 无显著性差异),而下肢中层钙化的基线患病率未观察到显著差异(男性为15%对21%,女性为9%对10%)。糖尿病患者和对照受试者中,两性主动脉钙化以及男性下肢钙化的5年发病率相似,但糖尿病女性下肢钙化的发病率高于对照女性(内膜:33%对11%,P = 0.009;中层:29%对14%,P = 0.05)。在随访期间出现间歇性跛行的受试者中,腹主动脉(糖尿病患者为37%对22%,P = 无显著性差异;对照受试者为42%对16%,P = 0.02)、下肢内膜(糖尿病患者为24%对16%,P = 无显著性差异;对照受试者为15%对7%,P = 无显著性差异)和中层钙化(糖尿病患者为23%对7%,P = 0.03)的基线患病率高于在5年检查时未出现间歇性跛行的受试者。VLDL代谢异常和高收缩压与糖尿病患者主动脉钙化的发展有关。总之,在诊断时,2型糖尿病患者的动脉粥样硬化钙化就比非糖尿病受试者更普遍。在随访期间,糖尿病女性而非男性下肢内膜和中层钙化的发病率高于非糖尿病受试者。在糖尿病和对照受试者的随访中,动脉钙化往往与间歇性跛行的发生有关。